-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, there have been reports that a number of Chinese patent medicine companies have announced that they will increase the prices of medicines due to the price increase of Chinese herbal medicines
.
In addition, some people in the industry said that most of the Chinese herbal medicines sold in the Qingping Chinese herbal medicine market in Guangzhou are still increasing in price, especially the nourishing herbs
.
Analysts divide that the main reason for the general rise in the price of Chinese herbal medicines is the mismatch between supply and demand
.
On the demand side, the recognition of Chinese patent medicines has been significantly improved, and the demand is increasing; on the supply side, the prices of Chinese herbal medicines have continued to decline in the past few years, and farmers are not very motivated, resulting in a decline in the planting area and the supply of Chinese herbal medicines.
caused a certain impact
.
In addition, in 2021, due to bad weather and heavy rains, the production of Chinese medicinal materials in Henan and other places will face a significant reduction, and the prices of most Chinese medicinal materials will also rise sharply
.
For pharmaceutical companies, in the case of rising raw material prices, it is natural for the prices of related pharmaceutical products to rise
.
However, despite the sharp rise in the price of Chinese herbal medicines, it is not all bad news
.
It is reported that many Chinese herbal medicine market sales are rising instead of falling
.
Previously, the person in charge of a Chinese herbal medicine e-commerce platform said that in 2021, the platform's sales of Chinese herbal medicines will be around 30 billion yuan, a year-on-year increase of 5%
.
At present, on the whole, although the reasons for the price increases of many Chinese patent medicine companies are different, most of them are inseparable from the price increase of the raw materials themselves and the adjustment of drug production lines
.
In this regard, the industry believes that for related enterprises, it is necessary to strengthen the connection and technical guidance with Chinese herbal medicine growers from the aspect of planting, to ensure the orderly development of the supply-side herbs, and to continuously improve the quality of Chinese herbal medicines, in order to better.
Ensure the normal supply of qualified Chinese herbal medicines
.
The author has learned that, in fact, to deal with this problem in the future, many traditional Chinese medicine companies have begun to take active measures in raw materials
.
For example, Jiuzhitang is strengthening the market monitoring of key materials and carrying out strategic reserve and inventory management in a timely manner to stabilize the risk of raw material price fluctuations
.
At the same time, the company is constantly improving the level of production technology, optimizing the production process of products, and controlling production costs.
.
Exceptionally, Taiji Group has been making efforts to build its own planting bases in recent years
.
As of March 2020, it has more than 100,000 mu of Chinese herbal medicine bases such as Pinellia, Qianhu, Golden Buckwheat, Perilla, Atractylodes, and Huoxiang
.
In addition, the company is also implementing the "three changes" cooperative planting model of "farmers + village collectives + cooperatives + leading enterprises", and has formulated a three-guarantee policy of "including seeds, technology, and purchases".
Ways to extend the industrial chain, enhance the value chain, improve the interest chain, establish a traceability system for the quality of Chinese herbal medicines, scale, standardize and standardize the Chinese herbal medicine industry, and enhance the market competitiveness of Chinese herbal medicines
.
Of course, in addition to the measures taken by pharmaceutical companies to deal with rising raw material prices, consumers should also buy rationally and avoid hoarding and abusing them; at the same time, pharmacists also need to fulfill their obligation to remind the expiration date of drugs
.
.
In addition, some people in the industry said that most of the Chinese herbal medicines sold in the Qingping Chinese herbal medicine market in Guangzhou are still increasing in price, especially the nourishing herbs
.
Analysts divide that the main reason for the general rise in the price of Chinese herbal medicines is the mismatch between supply and demand
.
On the demand side, the recognition of Chinese patent medicines has been significantly improved, and the demand is increasing; on the supply side, the prices of Chinese herbal medicines have continued to decline in the past few years, and farmers are not very motivated, resulting in a decline in the planting area and the supply of Chinese herbal medicines.
caused a certain impact
.
In addition, in 2021, due to bad weather and heavy rains, the production of Chinese medicinal materials in Henan and other places will face a significant reduction, and the prices of most Chinese medicinal materials will also rise sharply
.
For pharmaceutical companies, in the case of rising raw material prices, it is natural for the prices of related pharmaceutical products to rise
.
However, despite the sharp rise in the price of Chinese herbal medicines, it is not all bad news
.
It is reported that many Chinese herbal medicine market sales are rising instead of falling
.
Previously, the person in charge of a Chinese herbal medicine e-commerce platform said that in 2021, the platform's sales of Chinese herbal medicines will be around 30 billion yuan, a year-on-year increase of 5%
.
At present, on the whole, although the reasons for the price increases of many Chinese patent medicine companies are different, most of them are inseparable from the price increase of the raw materials themselves and the adjustment of drug production lines
.
In this regard, the industry believes that for related enterprises, it is necessary to strengthen the connection and technical guidance with Chinese herbal medicine growers from the aspect of planting, to ensure the orderly development of the supply-side herbs, and to continuously improve the quality of Chinese herbal medicines, in order to better.
Ensure the normal supply of qualified Chinese herbal medicines
.
The author has learned that, in fact, to deal with this problem in the future, many traditional Chinese medicine companies have begun to take active measures in raw materials
.
For example, Jiuzhitang is strengthening the market monitoring of key materials and carrying out strategic reserve and inventory management in a timely manner to stabilize the risk of raw material price fluctuations
.
At the same time, the company is constantly improving the level of production technology, optimizing the production process of products, and controlling production costs.
.
Exceptionally, Taiji Group has been making efforts to build its own planting bases in recent years
.
As of March 2020, it has more than 100,000 mu of Chinese herbal medicine bases such as Pinellia, Qianhu, Golden Buckwheat, Perilla, Atractylodes, and Huoxiang
.
In addition, the company is also implementing the "three changes" cooperative planting model of "farmers + village collectives + cooperatives + leading enterprises", and has formulated a three-guarantee policy of "including seeds, technology, and purchases".
Ways to extend the industrial chain, enhance the value chain, improve the interest chain, establish a traceability system for the quality of Chinese herbal medicines, scale, standardize and standardize the Chinese herbal medicine industry, and enhance the market competitiveness of Chinese herbal medicines
.
Of course, in addition to the measures taken by pharmaceutical companies to deal with rising raw material prices, consumers should also buy rationally and avoid hoarding and abusing them; at the same time, pharmacists also need to fulfill their obligation to remind the expiration date of drugs
.
